Here is what clinicians recommend
If you fall into this category, the timing of your dose can influence its effectiveness
The vial contains 60 mg total semaglutide, which is the entire vial supply for multiple weeks of once-weekly dosing
This activation enhances glucose-dependent insulin secretion, suppresses inappropriate glucagon release, delays gastric emptying, and reduces appetite through central nervous system pathways
Appointments are quick and straightforward, with little to no downtime
Interestingly, tirzepatide, a dual-acting GIP/GLP-1 receptor agonist that is now clinically approved for both obesity and T2D, was designed with an amino acid sequence closely resembling that of native GIP, resulting in strong preference for GIPR binding over the GLP-1R